Thus, reduced expression of ACE2 in the kidneys, which reduces the ACE/ACE2 ratio, has been suggested as a possible cause of local vasoconstriction and inflammation, necrosis, and kidney damage in COVID-19 patients [225,226]. The gene discussed is ACE2; the disease is COVID-19.